Polymorph of 3-(substituteddihydroisoindolinone-2-yl) -2,6-dioxopiperidine, and pharmaceutical compositions thereof

Details for Australian Patent Application No. 2010312224 (hide)

Owner Yan, R. Nanjing Cavendish BioEngineering Technology Co., Ltd.

Inventors Yan, Rong; Yang, Hao; Xu, Yongxiang

Agent FB Rice

Pub. Number AU-A-2010312224

PCT Pub. Number WO2011/050590

Priority 200910210392.3 02.11.09 CN

Filing date 2 November 2010

Wipo publication date 5 May 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/050590 Priority application(s): WO2011/050590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010312238-Concentrated therapeutic phospholipid compositions

2010312210-Securely locating device for intravital lumen